271 related articles for article (PubMed ID: 20176609)
1. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.
Nasrallah MM; El-Shehaby AR; Salem MM; Osman NA; El Sheikh E; Sharaf El Din UA
Nephrol Dial Transplant; 2010 Aug; 25(8):2679-85. PubMed ID: 20176609
[TBL] [Abstract][Full Text] [Related]
2. Aortic calcification in haemodialysis patients with diabetes mellitus.
Taniwaki H; Ishimura E; Tabata T; Tsujimoto Y; Shioi A; Shoji T; Inaba M; Inoue T; Nishizawa Y
Nephrol Dial Transplant; 2005 Nov; 20(11):2472-8. PubMed ID: 16077143
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.
Kojima F; Uchida K; Ogawa T; Tanaka Y; Nitta K
Int Urol Nephrol; 2008; 40(4):1067-74. PubMed ID: 18791804
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis.
Yamada K; Fujimoto S; Nishiura R; Komatsu H; Tatsumoto M; Sato Y; Hara S; Hisanaga S; Ochiai H; Nakao H; Eto T
Nephrol Dial Transplant; 2007 Jul; 22(7):2032-7. PubMed ID: 17395663
[TBL] [Abstract][Full Text] [Related]
5. Lateral lumbar X-ray assessment of abdominal aortic calcification in Australian haemodialysis patients.
Toussaint ND; Pedagogos E; Lau KK; Heinze S; Becker GJ; Beavis J; Polkinghorne KR; Damasiewicz MJ; Kerr PG
Nephrology (Carlton); 2011 May; 16(4):389-95. PubMed ID: 21054667
[TBL] [Abstract][Full Text] [Related]
6. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis.
El Baz TZ; Khamis OA; Ahmed Gheith OA; Abd Ellateif SS; Abdallah AM; Abd El Aal HC
Saudi J Kidney Dis Transpl; 2017; 28(1):51-60. PubMed ID: 28098103
[TBL] [Abstract][Full Text] [Related]
7. Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients.
Inaba M; Okuno S; Imanishi Y; Yamada S; Shioi A; Yamakawa T; Ishimura E; Nishizawa Y
Osteoporos Int; 2006 Oct; 17(10):1506-13. PubMed ID: 16896512
[TBL] [Abstract][Full Text] [Related]
8. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.
Jean G; Bresson E; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2009 Mar; 24(3):948-55. PubMed ID: 18852190
[TBL] [Abstract][Full Text] [Related]
9. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients.
Nitta K; Akiba T; Uchida K; Otsubo S; Takei T; Yumura W; Kabaya T; Nihei H
Nephrol Dial Transplant; 2004 Jul; 19(7):1886-9. PubMed ID: 15128884
[TBL] [Abstract][Full Text] [Related]
10. Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease.
Tatami Y; Yasuda Y; Suzuki S; Ishii H; Sawai A; Shibata Y; Ota T; Shibata K; Niwa M; Morimoto R; Hayashi M; Kato S; Maruyama S; Murohara T
Atherosclerosis; 2015 Dec; 243(2):349-55. PubMed ID: 26519631
[TBL] [Abstract][Full Text] [Related]
11. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
[TBL] [Abstract][Full Text] [Related]
12. Calcification of abdominal aorta in patients recently starting hemodialysis: A single-center experience from Egypt.
Fayed A; Elnokeety MM; Attia K; Sharaf El Din UA
Saudi J Kidney Dis Transpl; 2019; 30(4):819-824. PubMed ID: 31464238
[TBL] [Abstract][Full Text] [Related]
13. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
Takei T; Otsubo S; Uchida K; Matsugami K; Mimuro T; Kabaya T; Akiba T; Nitta K
Nephron Clin Pract; 2008; 108(4):c278-83. PubMed ID: 18434749
[TBL] [Abstract][Full Text] [Related]
14. Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis.
Tamei N; Ogawa T; Ishida H; Ando Y; Nitta K
J Atheroscler Thromb; 2011; 18(3):217-23. PubMed ID: 21139318
[TBL] [Abstract][Full Text] [Related]
15. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.
Roos M; Lutz J; Salmhofer H; Luppa P; Knauss A; Braun S; Martinof S; Schömig A; Heemann U; Kastrati A; Hausleiter J
Clin Endocrinol (Oxf); 2008 Apr; 68(4):660-5. PubMed ID: 17970775
[TBL] [Abstract][Full Text] [Related]
16. Assessment and significance of abdominal aortic calcification in chronic kidney disease.
Hanada S; Ando R; Naito S; Kobayashi N; Wakabayashi M; Hata T; Sasaki S
Nephrol Dial Transplant; 2010 Jun; 25(6):1888-95. PubMed ID: 20061316
[TBL] [Abstract][Full Text] [Related]
17. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.
Turan MN; Kircelli F; Yaprak M; Sisman AR; Gungor O; Bayraktaroglu S; Ozkahya M; Asci G; Floege J; Ok E
Int Urol Nephrol; 2016 Apr; 48(4):609-17. PubMed ID: 26865177
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial.
Toussaint ND; Lau KK; Polkinghorne KR; Kerr PG
Nephrology (Carlton); 2011 Mar; 16(3):290-8. PubMed ID: 21342323
[TBL] [Abstract][Full Text] [Related]
19. The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers.
Nasrallah MM; El-Shehaby AR; Osman NA; Fayad T; Nassef A; Salem MM; Sharaf El Din UA
Nephron Extra; 2013; 3(1):106-112. PubMed ID: 24348506
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of aortic calcification with lanthanum carbonate vs. calcium-based phosphate binders in maintenance hemodialysis patients with type 2 diabetes mellitus: an open-label randomized controlled trial.
Wada K; Wada Y
Ther Apher Dial; 2014 Aug; 18(4):353-60. PubMed ID: 24417760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
